The Committee for Medicinal Products for Human Use (CHMP) meets once a month. The meetings of the CHMP are not public. Currently, no agendas or minutes of the meetings are published. After each CHMP meeting, the Agency publishes a table highlighting the main decisions taken in the meeting.
In addition, the Agency publishes summaries of the opinions adopted during each meeting on specific medicines. These express the opinion of the CHMP on new marketing-application dossiers from pharmaceutical companies, on referral procedures and on other issues on which the Committee is required to provide an opinion.
16/12/2013 - 19/12/2013 : CHMP
The Committee for Medicinal Products for Human Use (CHMP) is the committee that is responsible for preparing the Agency's opinions on all questions concerning human medicines. It does not currently publish the minutes or agendas of its meetings. It does publish highlights after each meeting.